Tatva Chintan Pharma Chem (BOM:543321) ROCE % : 7.53% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Tatva Chintan Pharma Chem ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Tatva Chintan Pharma Chem's annualized ROCE % for the quarter that ended in Mar. 2024 was 7.53%.

Tatva Chintan Pharma Chem ROCE % Historical Data

The historical data trend for Tatva Chintan Pharma Chem's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tatva Chintan Pharma Chem ROCE % Chart

Tatva Chintan Pharma Chem Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

Get a 7-Day Free Trial

37.19

36.13

31.73

10.56

7.96

Tatva Chintan Pharma Chem Quarterly Data
	Mar19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial												8.46	12.57	7.79	3.08	7.53

Tatva Chintan Pharma Chem ROCE % Calculation

Tatva Chintan Pharma Chem's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	501	/	( ( (7563 - 2361.34)	+	(8187.18 - 796.63) )	/ 2 )
	=	501	/	( (5201.66	+	7390.55)	/ 2 )
	=	501	/	6296.105
	=	7.96 %

Tatva Chintan Pharma Chem's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	556.2	/	( ( (0 - 0)	+	(8187.18 - 796.63) )	/ 1 )
	=	556.2	/	( ( 0	+	7390.55 )	/ 1 )
	=	556.2	/	7390.55
	=	7.53 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Tatva Chintan Pharma Chem (BOM:543321) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Tatva Chintan Pharma Chem ROCE % Related Terms

Thank you for viewing the detailed overview of Tatva Chintan Pharma Chem's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Tatva Chintan Pharma Chem (BOM:543321) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Tatva Chintan Pharma Chem Ltd (BOM:543321) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

TATVA:India

Address

Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010

Website

https://www.tatvachintan.com

Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.

Tatva Chintan Pharma Chem (BOM:543321) Headlines

No Headlines